Back

Safety and feasibility of pulmonary vein isolation for atrial fibrillation in morbidly obese patients with a body mass index of more than 40 kg/m2.

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial Fibrillation - Treatment Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Nico Reinsch

Alfried-Krupp-Hospital Ruttenscheid, Essen (Germany)

61 More presentations in this session

Presentation thumbnail
Mapping persistent atrial fibrillation with a high-density grid-style catheter: procedural characteristics and ablation lesion distribution
Professor P. Gora (Bad Oeynhausen, DE)
Abstract Slides
Presentation thumbnail
Distribution of reablated antral segments after initial pulmonary vein isolation with use of ablation index.
Professor K. Neven (Essen, DE)
Abstract Slides
Presentation thumbnail
One-year clinical outcome after pulmonary vein isolation with use of ablation index in patients with persistent atrial fibrillation.
Professor N. Reinsch (Essen, DE)
Abstract Slides
Presentation thumbnail
Safety and feasibility of a minimally fluoroscopic approach during pulmonary vein isolation for atrial fibrillation.
Professor N. Reinsch (Essen, DE)
Abstract Slides
Presentation thumbnail
Use of Ablation Index significantly reduces the incidence of cardiac tamponade complicating pulmonary vein isolation for atrial fibrillation.
Professor K. Neven (Essen, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Atrial Fibrillation - Treatment

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources